scispace - formally typeset
F

Flavia Radogna

Researcher at University of Rome Tor Vergata

Publications -  31
Citations -  6751

Flavia Radogna is an academic researcher from University of Rome Tor Vergata. The author has contributed to research in topics: Apoptosis & Melatonin. The author has an hindex of 21, co-authored 31 publications receiving 6143 citations.

Papers
More filters
Journal ArticleDOI

Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition)

Daniel J. Klionsky, +2522 more
- 21 Jan 2016 - 
TL;DR: In this paper, the authors present a set of guidelines for the selection and interpretation of methods for use by investigators who aim to examine macro-autophagy and related processes, as well as for reviewers who need to provide realistic and reasonable critiques of papers that are focused on these processes.
Journal ArticleDOI

Melatonin: a pleiotropic molecule regulating inflammation

TL;DR: The interesting timing of pro- and anti-inflammatory effects, such as those affecting lipoxygenase activity, suggests that melatonin might promote early phases of inflammation on one hand and contribute to its attenuation on the other hand, in order to avoid complications of chronic inflammation.
Journal ArticleDOI

Cancer-type-specific crosstalk between autophagy, necroptosis and apoptosis as a pharmacological target.

TL;DR: The effects of pharmacologically active compounds as modulators of different types of cancer cell death depending on the cellular context are summarized to highlight the potential role of these compounds for context-specific anticancer therapy.
Journal ArticleDOI

Melatonin antagonizes the intrinsic pathway of apoptosis via mitochondrial targeting of Bcl-2.

TL;DR: It is shown that melatonin interferes with the intrinsic pathway of apoptosis at the mitochondrial level, providing a mechanism that may explain how melatonin through interaction with the MT1/MT2 receptors, elicits a pathway that interfered with the Bcl‐2 family, thus modulating the cell life/death balance.
Journal ArticleDOI

Stress-induced cellular responses in immunogenic cell death: Implications for cancer immunotherapy.

TL;DR: The contribution of adaptive immunity to the long‐term clinical benefits of anticancer treatments and the properties of immune memory that can protect cancer patients against relapse are highlighted.